Answer
Linagliptin has no or negligible influence on driving or using machines, but patients should be alerted to hypoglycaemia risk, especially when it is combined with a sulphonylurea and/or insulin.
Sources for this answer
- Trajenta 5 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 18Document updated
Sources checked